Consistent with these data, ex vivo Treg cell suppression assays of CD4+CD25+ Treg cells sorted from tumor-bearing mice showed that Treg cells isolated from KC1-p53KO recipients were more efficient at inhibiting the proliferation of CD4+CD25− T cells in vitro (Figures 5F and S5F). Here, CD4 is linked to neoplasm.